About: Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $53.67 (+3.61%)
ETON NASDAQ Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc share price
Atividade de preço de ETON
Último preço
$ 53,670
Variação (24h)
1,87 USD (3,61%)
Volume
366.24K
Volume (média 4 sem.)
-
Abertura
$ 52,10
Variação do dia
$ 51,98 - $ 53,98
Fechamento anterior
$ 51,80
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ETON price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals